Nath Bio-Genes (India) Ltd.

•

nathbiogenes.comBSE: 537291NSE: NATHBIOGEN

Market Cap₹ 281 Cr.

Current Price

High / Low₹ 204 / 126

Stock P/E5.9

Book Value₹ 380

Price to Book0.43

Dividend Yield1.35 %

ROCE7.3 %

ROE6.7 %

Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • Agriculture Activities: 87.4% • Trading Activity: 12.6%

AI Sector View

AI GENERATED

Fast Moving Consumer Goods

Hold

Rural demand proxies are mixed. Tractor sales rose 18.0% YoY (2026-07) and 2-wheelers were up 23.0% YoY (2026-06), but rural employment slowed to 1.0% YoY (2026-07), fertiliser sales were 0.0% YoY (2026-05), and food inflation of 5.52% (Jul/26) can pressure household budgets. FPI outflows remain heavy at INR -8081 crore over 3 months to 2026-08-31, limiting upside.

Confidence

62%

View full sector analysis →

PROS

Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.19x)
Company generates healthy free cash flow
Company has a consistent dividend-paying track record
Company maintains a comfortable, low leverage position

CONS

Recent results are weak - TTM profit is down 32.6% versus prior year
Company has a low return on capital employed of 7.2%
Company has a low return on equity of 6.6% over last 3 years
Company has delivered a poor profit growth of -3.5% over past five years
Effective tax rate is unusually low at 4.5% - earnings may be flattered
Company has delivered a poor sales growth of 5.3% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Fast Moving Consumer GoodsAgriAgriculture

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	KSCL	715.75	14.75	3681.75	0.00	279.84	-14.47	742.50	-13.51	21.77	39.58
2.	VENKEYS	1786.55	366.34	2516.77	0.56	49.99	215.79	1118.38	29.17	11.27	6.18
3.	AVTNPL	89.96	16.35	1369.95	0.89	31.10	156.69	241.22	82.16	14.26	16.56
4.	BSHSL	90.00	32.92	944.44	0.00	14.30	16.56	182.57	19.37	21.19	9.39
5.	REGAAL	83.83	14.43	863.40	0.30	13.33	46.95	202.15	-18.02	16.91	15.33
6.	MGEL	15.94	11.13	525.31	0.06	84.26	1210.01	9520.65	1008.93	19.37	1.94
7.	NATHBIOGEN	147.80	7.67	280.88	1.35	32.26	-13.46	328.40	15.76	6.89	10.70
8.	MSL	149.00	19.67	163.60	0.00	3.97	1.93	61.84	25.81	12.34	9.28
9.	INDOUS	77.61	30.74	155.62	0.00	3.04	-35.38	32.99	7.21	21.15	12.01
10.	OSWALSEEDS	15.54	11.64	142.14	0.00	12.27	68.60	117.08	19.53	9.88	15.65
11.	NARMADA	14.31	30.22	108.57	0.00	7.54	—	222.63	—	8.94	4.25
12.	AGRITECH	99.95	0.00	59.37	0.00	-3.61	61.18	0.00	—	-0.94	—

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	235	23	32	43	244	32	37	49	280	40	66	46	323
	198	17	26	39	207	26	29	46	241	33	57	39	293
Operating Profit	37	5	6	4	37	7	7	3	39	7	9	7	30
OPM %	15.79%	22.55%	18.24%	10.41%	15.20%	20.38%	20.34%	6.42%	13.88%	18.08%	13.39%	14.47%	9.38%
	0	0	3	0	0	0	0	4	2	2	4	4	1
Interest	3	2	3	1	2	3	3	1	3	3	4	3	4
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1
Profit before Tax	34	2	5	3	34	3	4	5	37	5	8	6	33
Tax %	0.65%	17.86%	16.31%	21.60%	0.73%	-1.05%	30.08%	13.12%	1.79%	13.22%	10.74%	39.75%	2.16%
Net Profit	34	2	4	2	34	3	3	4	36	4	7	4	33
	17.58	0.85	2.09	2.18	17.77	1.46	1.40	2.12	20.06	2.16	3.80	2.17	17.18

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	162	170	192	231	280	308	278	301	333	362	474
	137	141	151	188	225	241	241	252	282	310	421
Operating Profit	25	29	40	43	55	67	37	49	50	52	53
OPM %	15.20%	17.07%	21.11%	18.78%	19.58%	21.71%	13.39%	16.31%	15.17%	14.46%	11.16%
	1	1	1	2	2	2	-87	1	4	5	11
Interest	6	10	10	5	7	9	11	10	9	10	14
Depreciation	4	3	1	1	1	3	3	3	3	4	4
Profit before Tax	15	17	30	39	49	57	-63	36	42	44	53
Tax %	6.04%	2.81%	2.12%	1.12%	-4.07%	1.92%	-6.23%	3.17%	4.62%	4.50%	8.99%
Net Profit	14	16	29	38	50	56	-67	35	40	42	48
EPS	0.00	0.00	0.00	0.00	0.00	29.00	-35.52	18.51	21.14	22.17	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	6.83%	-5.64%	10.81%	9.46%	9.02%	—

COMPOUNDED SALES GROWTH

10 Years:: 7%
5 Years:: 5%
3 Years:: 9%

COMPOUNDED PROFIT GROWTH

10 Years:: 5%
5 Years:: -4%
3 Years:: —

STOCK PRICE CAGR

10 Years:: 4%
5 Years:: -15%
3 Years:: -11%
1 Year:: -13%

RETURN ON EQUITY

10 Years:: 6%
5 Years:: 4%
3 Years:: 7%
Last Year:: 7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	19	19	19	19	19	19	19	19
	105	287	450	489	539	594	523	554	592	630
	58	69	32	58	70	99	92	104	107	110
Trade Payables	48	44	37	50	68	35	43	28	42	79
	39	38	32	32	34	42	63	87	117	180
Total Liabilities	266	454	570	648	729	790	740	793	877	1,017
	30	207	211	232	246	247	245	244	249	250
	5	5	5	5	5	5	5	5	6	6
	141	130	123	155	204	226	220	208	229	331
	0	0	0	0	0	0	0	0	94	89
Cash & Bank	1	6	45	21	22	29	4	38	76	88
	88	106	186	234	252	282	265	298	223	253
Total Assets	266	454	570	648	729	790	740	793	877	1,017

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	-14	3	-47	-20	11	1	20	39	75	27
Cash from Investing	-17	-4	-4	-20	-14	-10	-20	-3	-27	-4
Cash from Financing	30	5	90	20	6	16	-22	-2	-10	-11
	-0	5	39	-23	1	7	-25	34	38	12

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60	45.60
	0.21	0.18	0.19	0.21	0.41	0.32	0.31	0.22	0.26
	4.37	4.37	4.37	3.94	2.25	0.76	0.01	0.01	0.01
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	49.82	49.85	49.84	50.25	51.74	53.32	54.08	54.17	54.13

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-09

Clarification - Financial Results

2026-09-09 - The Exchange has sought clarification from Nath Bio-Genes (India) Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.

2026-09-01

Record Date

2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.

2026-09-01

Shareholders meeting

2026-09-01 - Nath Bio-Genes (India) Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-06

Initiation of Forensic Audit

2026-08-06 - Nath Bio-Genes (India) Limited has informed the Exchange about Initiation of Forensic Audit

2026-07-30

General Updates

2026-07-30 - Nath Bio-Genes (India) Limited has informed the Exchange about General Updates

2026-07-29

Outcome of Board Meeting

2026-07-29 - Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-23

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-23 - Nath Bio-Genes (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-06-26

Trading Window

2026-06-26 - Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

2026-06-19

Disclosure under SEBI Takeover Regulations

2026-06-19 - Nath Bio-Genes (India) Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

News

Recent coverage and analyst commentary for NATHBIOGEN

Loading news…

🤖

AI Stock Analyst

Nath Bio-Genes (India) Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account